Electroacupuncture for treating the cognitive symptoms of Alzheimer’s disease: a randomized controlled trial - Scorecard - MDSpire

Electroacupuncture for treating the cognitive symptoms of Alzheimer’s disease: a randomized controlled trial

  • By

  • Ran Li

  • Zehao Chen

  • Yuhang Jiang

  • Shanshan Yan

  • Jiakai He

  • Jinrong Yan

  • Guanhua Zong

  • Zongxi Yi

  • Xinyu Ren

  • Baohui Jia

  • May 4, 2026

  • 0 min

Share

Clinical Scorecard: Electroacupuncture's Impact on Cognitive Symptoms in Alzheimer's Disease: Results from a Randomized Controlled Trial

At a Glance

CategoryDetail
Condition
Key MechanismsElectroacupuncture may enhance synaptic plasticity, increase synaptic density, regulate cholinergic neurotransmission, inhibit tau hyperphosphorylation, and reduce neuroinflammation, but these mechanisms need to be directly linked to clinical outcomes.
Target Population
Care Setting

Key Highlights

  • improvements

Guideline-Based Recommendations

Diagnosis

    Management

    • I
    • n
    • c
    • l
    • u
    • d
    • e
    • a
    • d
    • d
    • i
    • t
    • i
    • o
    • n
    • a
    • l
    • m
    • a
    • n
    • a
    • g
    • e
    • m
    • e
    • n
    • t
    • s
    • t
    • r
    • a
    • t
    • e
    • g
    • i
    • e
    • s
    • a
    • n
    • d
    • c
    • o
    • n
    • s
    • i
    • d
    • e
    • r
    • a
    • t
    • i
    • o
    • n
    • s
    • f
    • o
    • r
    • c
    • o
    • m
    • p
    • r
    • e
    • h
    • e
    • n
    • s
    • i
    • v
    • e
    • c
    • a
    • r
    • e
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Discuss potential limitations or contraindications of electroacupuncture.

        Clinical Best Practices

        • recommendations

        References

        Original Source(s)

        Electroacupuncture for treating the cognitive symptoms of Alzheimer’s disease: a randomized controlled trial

        • by Ran Li, Zehao Chen, Yuhang Jiang, Shanshan Yan, Jiakai He, Jinrong Yan, Guanhua Zong, Zongxi Yi, Xinyu Ren, Baohui Jia

        • May 4, 2026

        Related Content

        What Should Doctors Know About FDA’s Black Box Change for Hormone Replacement Therapy Drugs?

        A Keck Medicine of USC breast surgeon discusses the FDA’s decision — and whether using HRT to treat menopause symptoms actually affects breast cancer risk.

        • by

        • January 28, 2026

        • 8 min
        Enrique Diaz, M.D., Joins Baptist Health Miami Neuroscience Institute as a Psychiatrist

        Board-certified psychiatrist Enrique Diaz, M.D., has joined Baptist Health Miami Neuroscience Institute, part of Baptist Health Brain & Spine Care.

        • by

        • April 30, 2026

        • 2 min
        Neurological manifestations in people with HIV in HAART era: a cross-sectional multicenter study